Sorry, you need to enable JavaScript to visit this website.

Pfizer Oncology Press Kit

PLEASE NOTE: All assets on this page are intended for use by U.S. media professionals only.

Over the past decade Pfizer Oncology has taken bold new approaches to translate scientific research into effective medicines for people living with cancer. We are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

For the latest information on our growing pipeline, product portfolio and collaborations with the broader cancer community, visit this page periodically for updates.

Learn more and download an overview of our products pipeline and strategic approach.

PFIZER ABSTRACT PLAIN LANGUAGE SUMMARIES (APLS)

To help interested non-scientists better understand the latest research, we are developing summaries in plain language for Pfizer research results presented at medical conferences. We call these “abstract plain language summaries” (APLS).

Visit www.pfizer.com/APLS to learn more

 
CHANGING THE TRAJECTORY OF CANCER TAKES FOCUS – AT SCALE

18.1 million. That’s the total number of new cancer cases per year expected worldwide in 2018. In Europe specifically, the number of people who will be diagnosed with cancer this year is roughly 4.2 million.

Read More
MAPPING THE FUTURE ONCOLOGY LANDSCAPE: HOW WE CAN BUILD UPON IMMUNO-ONCOLOGY

The potential for immunotherapy to transform the lives of people with cancer is vast – and the mountain of data continues to grow. But no matter how effective it may be in fighting certain cancers, it is not – and should not be – the only approach.

Read More
HOW PATIENT-CENTRICITY DRIVES INNOVATION

In oncology, patients don’t just inspire innovation. They drive it. By its very nature, precision medicine – the cutting edge of oncology – focuses our efforts on people with distinct underlying biological characteristics.

Read More

GET TO KNOW PFIZER

 

Additional Pfizer Oncology Resources

View a glossary of commonly used terms in cancer diagnosis, testing and treatment.

View how Pfizer Oncology has helped transform cancer care for nearly two decades.

Learn how researchers have developed a heat index to classify tumors based on these factors.